天弘医药创新A（010654）成立日期2020年12月2日，最新规模7.07亿。今年以来收益65.45%，同类排 名432/8172；近一年收益91.51%，同类排名853/7995；成立以来收益21.57%。 天弘医药创新A（010654）基金经理为郭相博。 从博腾股份十大流通股东角度 数据显示，天弘基金旗下1只基金位居博腾股份十大流通股东。天弘医药创新A（010654）二季度减持 51.39万股，持有股数639.8万股，占流通股的比例为1.28%。根据测算，今日浮亏损失约850.94万元。 9月23日，博腾股份跌5.04%，截至发稿，报25.06元/股，成交3.05亿元，换手率2.37%，总市值136.69亿 元。 资料显示，重庆博腾制药科技股份有限公司位于重庆市北碚区云图路7号，成立日期2005年7月7日，上 市日期2014年1月29日，公司主营业务涉及化学原料药CDMO业务、化学制剂CDMO业务和生物CDMO 业务(包括基因疗法和细胞疗法)。主营业务收入构成为：临床后期及商业化业务66.81%，临床早期业务 25.76%，新兴业务7.11%，其他(补充)0.32%。 截至发稿，郭相博累计任职时间7年2 ...

Core Insights - The article provides a ranking of open-end funds based on their net asset value growth as of August 19, 2025, highlighting the top and bottom performers in the market [2][4][6]. Group 1: Top Performing Funds - The top 10 funds with the highest net value growth include: 1. 永赢先进制造智选混合发起A with a net value of 2.2009, up from 2.1183, a change of 0.08 [2]. 2. 永赢先进制造智选混合发起C with a net value of 2.1814, up from 2.0996, a change of 0.08 [2]. 3. 国泰中证全指通信设备ETF with a net value of 2.1083, up from 2.0296, a change of 0.07 [2]. 4. 永赢新能源智选混合发起A with a net value of 0.4356, up from 0.4202, a change of 0.01 [2]. 5. 永赢新能源智选混合发起C with a net value of 0.4302, up from 0.4150, a change of 0.01 [2]. 6. 恒越智选科技混合A with a net value of 1.2691, up from 1.2259, a change of 0.04 [2]. 7. 恒越智选科技混合C with a net value of 1.2579, up from 1.2151, a change of 0.04 [2]. 8. 宝盈睿丰创新混合C with a net value of 2.4800, up from 2.3970, a change of 0.08 [2]. 9. 宝盈睿丰创新混合A/B with a net value of 2.8740, up from 2.7780, a change of 0.09 [2]. 10. 天弘中证全指通信设备指数发起C with a net value of 1.7918, up from 1.7325, a change of 0.05 [2]. Group 2: Bottom Performing Funds - The bottom 10 funds with the lowest net value growth include: 1. 天弘医药创新A with a net value of 1.0704, down from 1.1038, a change of -0.03 [4]. 2. 天弘医药创新C with a net value of 1.0510, down from 1.0837, a change of -0.03 [4]. 3. 华安优势精选混合C with a net value of 0.8397, down from 0.8632, a change of -0.02 [4]. 4. 华安优势精选混合A with a net value of 0.8550, down from 0.8788, a change of -0.02 [4]. 5. 嘉实医疗保健股票 with a net value of 2.2010, down from 2.2590, a change of -0.05 [4]. 6. 华安沪港深机会灵活配置混合 with a net value of 2.2220, down from 2.2780, a change of -0.05 [4]. 7. 招商前沿医疗保健股票C with a net value of 0.6529, down from 0.6693, a change of -0.01 [4]. 8. 招商前沿医疗保健股票A with a net value of 0.6749, down from 0.6918, a change of -0.01 [4]. 9. 招商创新增长混合A with a net value of 0.8811, down from 0.9031, a change of -0.02 [4]. 10. 招商创新增长混合C with a net value of 0.8454, down from 0.8665, a change of -0.02 [4]. Group 3: Market Overview - The Shanghai Composite Index experienced a slight increase, while the ChiNext Index opened lower but recovered, with a trading volume of 2.64 trillion [6]. - The leading sectors included communication equipment, comprehensive categories, and diversified finance, all showing gains of over 2% [6]. - The fund with the fastest net value growth was identified as 永赢先进制造智选混合发起A [6].

Core Viewpoint - The article provides a ranking of open-end mutual funds based on their net asset value growth as of August 6, 2025, highlighting the top and bottom performers in the market [2][4][6]. Group 1: Top Performing Funds - The top 10 funds with the highest net value growth include: 1. Zhonghai Charm Yangtze River Delta Mixed Fund (3.1350) 2. Hengyue Smart Technology Mixed C Fund (1.1892) 3. Hengyue Smart Technology Mixed A Fund (1.1996) 4. Minsheng Jianyin Frontier Technology Mixed Fund (1.0201) 5. Tongtai Competitive Advantage Mixed A Fund (1.1032) 6. Tongtai Competitive Advantage Mixed C Fund (1.0802) 7. Furong Fuxin Mixed C Fund (2.1194) 8. Furong Fuxin Mixed A Fund (2.1560) 9. Hongyi Yuanfang Selected Mixed C Fund (1.1215) 10. Hongyi Yuanfang Selected Mixed A Fund (1.1231) [2][4]. Group 2: Bottom Performing Funds - The bottom 10 funds with the lowest net value growth include: 1. Guotai Innovation Medical Mixed Initiation C Fund (1.1799) 2. Guotai Innovation Medical Mixed Initiation A Fund (1.1901) 3. Wanjia Pharmaceutical Quantitative Stock Selection Mixed Initiation C Fund (1.2070) 4. Wanjia Pharmaceutical Quantitative Stock Selection Mixed Initiation A Fund (1.2165) 5. Morgan Stanley Youyue Anhe Mixed C Fund (0.6632) 6. Morgan Stanley Youyue Anhe Mixed A Fund (0.6727) 7. Hongde Medical Innovation Mixed Initiation A Fund (1.0426) 8. Hongde Medical Innovation Mixed Initiation C Fund (1.0274) 9. Guotai Growth Enterprise Board Medical Health ETF (1.2310) 10. Tianhong Medical Innovation A Fund (1.0690) [4][6]. Group 3: Market Overview - The Shanghai Composite Index showed a slight upward trend, with a trading volume of 1.75 trillion, and the number of advancing stocks was 3,357 compared to 1,817 declining stocks [6]. - Leading sectors included shipbuilding and general machinery, both rising over 3%, while the tourism sector experienced declines [6].